Patents Assigned to Eye Research Institute of Retina Foundation, Inc.
  • Patent number: 5051443
    Abstract: The composition and method of using a non-steroidal antiinflammatory compound, such as indomethacin and/or a growth factor that causes a change in cell function when bound to specific cell surface receptor, such as epidermal growth factor (EGF), to enhance healing and restore function of the corneal endothelium. The compositions can be administered alone, in combination, or in sequence, before or after injury, for example, in an irrigation solution or in combination with a nutritive solution for storage of cornea prior to transplant.
    Type: Grant
    Filed: April 13, 1989
    Date of Patent: September 24, 1991
    Assignee: Eye Research Institute of Retina Foundation, Inc.
    Inventors: Arthur H. Neufeld, Nancy C. Joyce, Marcia M. Jumblatt
  • Patent number: 5036046
    Abstract: Method using a non-steroidal antiinflammatory compound, such as indomethacin and/or a growth factor that causes a change in cell function when bound to a specific cell surface receptor, such as epidermal growth factor (EGF), to enhance healing and restore function of the corneal endothelium. The compositions can be adminsitered alone, in combination, or in sequence, before or after injury, for example, in an irrigation solution or in combination with a nutritive solution for storage of a cornea prior to transplant.Examples of useful growth factors include, in addition to EGF and EGF-like compounds, fragments of EGF containing the receptor binding region, and EGF modified to improve stability, increase half-life, or enhance permeation into the eye. Examples of other non-steroidal antiinflammatories include aspirin, ibuprofen, and suprofen. The composition can be applied topically to the eye or delivered in a controlled fashion by means of a material such as a polymeric implant, gel, or liposomes.
    Type: Grant
    Filed: October 12, 1988
    Date of Patent: July 30, 1991
    Assignee: Eye Research Institute of Retina Foundation, Inc.
    Inventors: Arthur H. Neufeld, Nancy C. Joyce, Marcia M. Jumblatt
  • Patent number: 5032575
    Abstract: Method using a non-steroidal antiinflammatory compound, such as indomethacin and/or a growth factor that causes a change in cell function when bound to a specific cell surface receptor, such as epidermal growth factor (EGF), to enhance healing and restore function of the corneal endothelium. The compositions can be administered alone, in combination, or in sequence, before or after injury, for example, in an irrigation solution or in combination with a nutritive solution for storage of a cornea prior to transplant.Examples of useful growth factors include, in addition to EGF and EGF-like compounds, fragments of EGF containing the receptor binding region, and EGF modified to improve stability, increase half-life, or enhance permeation into the eye. Examples of other non-steroidal antiinflammatories include aspirin, ibuprofen, and suprofen. The composition can be applied topically to the eye or delivered in a controlled fashion by means of a material such as a polymeric implant, gel, or liposomes.
    Type: Grant
    Filed: April 13, 1989
    Date of Patent: July 16, 1991
    Assignee: Eye Research Institute of Retina Foundation, Inc.
    Inventors: Arthur H. Neufeld, Nancy C. Joyce, Marcia M. Jumblatt
  • Patent number: 4142796
    Abstract: A beam of laser light is impinged on a vessel or vessels in which blood is flowing, such as vessels in the retina of the eye. The reflected light is detected with a photodetector to product a signal representative of the Doppler shift frequencies of the light scattered from the moving blood cells. If the light is impinged on a capillary bed the photodetector produces a homodyne type signal, from light reflected from blood in the various capillaries; if the light is impinged on a single vessel the photodetector produces a heterodyne type signal from the light reflected from the vessel wall and the light reflected from the blood cells flowing in the vessel. The signal from the photodetector is amplified and used to drive an audio output to produce a sound representative of the velocity of the blood.
    Type: Grant
    Filed: April 20, 1977
    Date of Patent: March 6, 1979
    Assignee: Eye Research Institute of Retina Foundation, Inc.
    Inventor: Charles E. Riva